Oncology has evolved from brute force chemotherapy to the use of increasingly targeted precision medicine approaches. Current oncology dynamics the REACH team is tracking include:
- The rise of antibody-drug conjugates (ADCs) and radiopharmaceuticals to improve selectivity of longstanding chemotherapy and radiation approaches and reduce off-target effects
- Next generation of immunotherapy treatment including allogenic CAR T, CAR T for solid tumors and bispecifics
- Precision approaches to improve treatment selection and response monitoring
Search Oncology diseases we cover